NCT00004211View on ClinicalTrials.gov

Vaccine Therapy in Treating Patients With Metastatic Prostate Cancer

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

July 31, 1999

Study Completion Date

January 31, 2002

Conditions
Prostate Cancer
Interventions
BIOLOGICAL

PSA RNA-pulsed dendritic cell vaccine

Trial Locations (1)

27710

Duke Comprehensive Cancer Center, Durham

Sponsors

Lead Sponsor

Duke University
All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Duke University

OTHER